MHRA-101288-PIP01-23

Key Facts

Active Substance
  • Interleukin-2
  • Interleukin-1 beta, human
  • Granulocyte colony-stimulating factor
  • Tumor necrosis factor-alpha
  • Interferon gamma
Invented Name
Multikine
PIP Number MHRA-101288-PIP01-23
Pharmaceutical form(s)
Pharmaceutical form(s):
  • Solution for injection
Therapeutic area
Therapeutic area:
  • Oncology
Conditions / Indications
Conditions / Indications:
  • Treatment of squamous cell carcinoma of the head and neck (SCCHN)
Route(s) of administration
  • Peritumoural use
  • Perilymphatic use
PIP applicant
Decision Type
Decision Type
W: decision granting a waiver in all age groups for the listed condition(s).
Compliance Check
Compliance Check
No
Compliance Check Decision Date
Compliance Check Procedure Number

Decision Document

Decision Document Decision Document on a Paediatric Investigation Plan (PIP):Interleukin-2 Interleukin-1 beta, human Granulocyte colony-stimulating factor Tumor necrosis factor-alpha Interferon gamma .pdf
Published Date 03/10/2024